Meeting
2023 ASCO Genitourinary Cancers Symposium
First look at the baseline characteristics of participants in IRONMAN, the international registry for men with advanced prostate cancer.
Authors
Lorelei A Mucci
Harvard T.H. Chan School of Public Health, Boston, MA
Lorelei A Mucci , Jake Vinson , Travis A. Gerke , Terry Hyslop , Lauren Howard , Robert Dreicer , Dana E. Rathkopf , Kim N. Chi , Emilio Esteban , Deborah Enting , Anders Bjartell , Scott T. Tagawa , David M. Nanus , Michael Ong , Pedro C. Barata , Sebastien J. Hotte , Marie Grant , Paul Villanti , Philip W. Kantoff , Daniel J. George
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 85)
DOI
10.1200/JCO.2023.41.6_suppl.85
Abstract #
85
Poster Bd #
C12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
IRONMAN: The international registry for men with advanced prostate cancer.
First Author: Daniel J. George
Poster
2024 ASCO Breakthrough
Changes in the treatment landscape of metastatic hormone-sensitive prostate cancer: A multicenter study.
First Author: Fumihiko Urabe
Poster
2022 ASCO Genitourinary Cancers Symposium
First look at patient reported outcomes from IRONMAN, the international registry of men with advanced prostate cancer.
First Author: Emily Rencsok
Poster
2024 ASCO Genitourinary Cancers Symposium
Interaction of age and benefit of treatment intensification in advanced prostate cancer: An aggregate meta-analysis of 14 randomized trials.
First Author: Alicia K. Morgans